Endometrial Ablation Devices Market

Market Definition:

The global Endometrial Ablation Devices Market size was valued at USD 1.87 billion in 2021 and is predicted to reach USD 2.82 billion by 2030 with a CAGR of 4.7% from 2022-2030. Endometrial ablation is a surgical procedure used to remove a layer of tissue in the uterus's endometrial lining in women with heavy menstrual bleeding who have failed medical therapy and avoid hysterectomy. This surgery is a short-term treatment, which is suggested when uterine draining is not controlled by medicines. It is a beneficial procedure as it is less invasive, can be operated at the emergency clinic or a doctor’s clinic, has less hospitalization rate, and offers faster recovery rates. Continuous technological development in women’s health space and the rise in the prevalence of gynecological disorders increases demand for endometrial ablation procedures.

Market Dynamics and Trends

The endometrial ablation market is majorly driven by the growth in the prevalence of menorrhagia, Abnormal Uterine Bleeding (AUB), PCOD, and rise in the public awareness about endometrial surgical procedures. As per data from the Centers for Disease Control and Prevention, every year about 10 million American women witness menorrhagia which is about 1 in 5 women. Similarly, according to the National Health Portal India, AUB has affected 9 to 14% of women between menarche and menopause.

Moreover, the growth in the prevalence of gynecological problems such as cervical cancer, menstrual disorders, and uterine fibroids and easy accessibility of advanced devices such as electrical and radiofrequency ablation boosts the market progression.

Expansion of innovative electrosurgery procedures used in endometrial ablation further drives the usage of these surgical procedures. The advancements in techniques include free-flowing hot fluid, where saline is heated and circulated within the uterus for minutes. This procedure is used for women with irregular uterus shapes, or who suffer from abnormal tissue growth, intracavity lesions, or uterine fibroids. While, cryoablation technology is significantly used owing to its cost-effectiveness, fewer side effects, and causes less damage to surrounding tissues, thus propelling its demand.

However, complications and risks related to endometrial ablation such as high fever, shortness of breath, and uterine perforation restrain the uptake of these procedures. Also, with the COVID-19 pandemic, all elective and outpatient interventional procedures were curbed or limited, hence affecting the endometrial ablation devices market growth to some extent.

On the contrary, the benefits of the endometrial ablation surgery that includes a short-time procedure, high-efficiency rate, quick recovery and minimizes pain along with the expansion of single-use disposable catheter balloon cartridges in thermal balloon procedure is expected to create ample growth opportunities for the market in the coming years.

Market Segmentations and Scope of the Study

The endometrial ablation devices market share is segmented on the basis of type, end-users and geography. On the basis of devices, the market is bifurcated into devices and procedures. Further, these devices are segmented into cryoablation devices, electrical ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, thermal balloon ablators, hysteroscopy devices and others.

On the basis of end-users, the market is categorized into ambulatory surgery centers, clinics, and hospitals. Geographic breakdown and analysis of each of the aforesaid segments include regions such as North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the maximum revenue share in the endometrial ablation devices market and is expected to continue its dominance during the forecast period. This is attributed to a high number of FDA-approved products and launches in this region. For instance, in March 2020, AEGEA Medical received FDA approval for its Mara Water Vapor Ablation System, designed to reduce heavy menstrual bleeding.

While,  Hologic, Inc. launched its NovaSure V5 Global Endometrial Ablation Device in November 2021. Also, the rise in cases of gynecological disorders promotes these procedures in this region. According to the U.S. Department of Health and Human Services, in the US 11% of women have endometriosis, which results in inflammation as the tissue responds to the monthly fluctuations of a woman's menstrual cycle.

On the other hand, Asia-Pacific is expected to show steady growth in the coming years due to increasing accessibility & availability of novel devices and rising cases of abnormal uterine bleeding and other complexities. As per October 2021 data from the International Journal of Gynecology & Obstetrics, there was a clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation in China. Moreover, steady rise in the number of ambulatory surgical centers paired with better infrastructure facilities incorporating advanced ablation techniques further boost regional growth.

Competitive Landscape

The endometrial ablation devices industry is operated by various market players such as Hologic Inc., CooperSurgical Inc. (AEGEA Medical Inc.), Medtronic Plc., Boston Scientific Corporation, Omnitech Systems, Inc., Olympus Corporation, Richard Wolf GmbH, Minerva Surgical Inc, AngioDynamics and Ethicon, Inc. (Johnson & Johnson). These market players are adopting various acquisitions and business expansion strategies to maintain their dominance in the market.

For instance, in February 2021, CooperSurgical acquired AEGEA Medical and its FDA-approved‘Mara endometrial removal therapy’ to extend its portfolio. While, in May 2020, Minerva acquired the Intrauterine Health franchise of Boston Scientific. This franchise includes a product portfolio for treating AUB, thus expanding the company’s presence in this market.

Key Benefits

• The endometrial ablation devices market report provides the quantitative analysis of the current market and estimations from 2022 to 2030. This analysis assists in identifying the prevailing market opportunities to capitalize on.

• The study comprises of an extensive analysis of the endometrial ablation devices market trends including the current and future trends for depicting the prevalent investment pockets in the market.

• The information related to key drivers, restraints, and opportunities, and their impact on the endometrial ablation devices market is provided in the report.

• The competitive analysis of the market players along with their market share in the endometrial ablation devices market is mentioned.

• The SWOT analysis and Porter’s Five Forces model are elaborated in the study.

• The value chain analysis in the market study provides a clear picture of the stakeholders’ roles. 

Endometrial Ablation Devices Market Key Segments

By Type

• Devices

  • Cryoablation Devices

  • Electrical Ablators 

  • Radiofrequency Endometrial Ablation Devices

  • Hydrothermal Ablators

  • Thermal Balloon Ablators

  • Hysteroscopy Devices

  • Others

• Procedures

By End-users

• Ambulatory Surgery Centers

• Clinics

• Hospitals

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Rest of Asia-Pacific

• RoW

  • UAE

  • Saudi Arabia

  • South Africa

  • Brazil

  • Remaining Countries

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2021	USD 1.87 Billion
Revenue Forecast in 2030	USD 2.82 Billion
Growth Rate	CAGR of 4.7% from 2022 to 2030
Analysis Period	2021–2030
Base Year Considered	2021
Forecast Period	2022–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rising public awareness about endometrial surgical procedures. Expansion of innovative electrosurgery procedures used in endometrial ablation further drives market growth.
Countries Covered	20
Companies Profiled	10
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent to up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

KEY PLAYERS:

• Hologic, Inc. 

• CooperSurgical Inc. (AEGEA Medical Inc.)

• Medtronic Plc

• Boston Scientific Corporation

• Omnitech Systems, Inc.

• Olympus Corporation

• Richard Wolf GmbH

• Minerva Surgical Inc

• AngioDynamics

• Ethicon, Inc. (Johnson & Johnson)